SCHEMBL1822285

SCHEMBL1822285

CCC(c1ccccc1)c1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
MAPT P10636 4/20 0.46
TDP1 Q9NUW8 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.42
METAP2 P50579 1/20 0.42
METAP1 P53582 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
CCR5 P51681 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
HTR6 P50406 1/20 0.39
HSD11B1 P28845 1/20 0.39
HSD17B3 P37058 1/20 0.39
PSIP1 O75475 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827857 0.91 LMNA (0.48) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL8526250 0.85 LMNA (0.50) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1825108 0.84 ALDH1A1 (0.47) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1824964 0.84 LMNA (0.36) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1826111 0.83 ALDH1A1 (0.49) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1821345 0.81 MAPT (0.46) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1824123 0.80 ALDH1A1 (0.46) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1826030 0.79 TDP1 (0.56) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1825093 0.79 SMN1; SMN2 (0.48) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A
SCHEMBL1822882 0.79 ALDH1A1 (0.45) ALDH1A1MAPTTDP1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ALDH1A1 1099/4885MAPT 4712/4885TDP1 4543/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ALDH1A1 1440/4885MAPT 2237/4885TDP1 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.